Gastric cancer (GC) cells display a striking reliance on glycolysis, driven by constitutive activation of the PI3K/AKT/mTOR signaling pathway and stabilization of HIF-1α—effects often amplified by Helicobacter pylori-associated chronic inflammation (50–56). Here, HIF1A is linked to gastric cancer.